Evaluating Alternative Fungicides for Effective Management of Rice Blast Disease: Inhibitory Effects on Pyricularia oryzae Cavara
Tricyclazole has been a successful solution for managing rice blast for over three decades. However, the continuous use of this fungicide has led to the development of resistance and the accumulation of tricyclazole residues within rice grains, prompting a ban on its usage in India. In response to t...
Saved in:
Published in | Journal of advances in biology & biotechnology Vol. 27; no. 10; pp. 1405 - 1411 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
23.10.2024
|
Online Access | Get full text |
Cover
Loading…
Summary: | Tricyclazole has been a successful solution for managing rice blast for over three decades. However, the continuous use of this fungicide has led to the development of resistance and the accumulation of tricyclazole residues within rice grains, prompting a ban on its usage in India. In response to this pressing issue, the present study aims to evaluate the efficacy of alternative fungicides in controlling the growth of Pyricularia oryzae, the causal agent of rice blast. The study employed a comprehensive approach, assessing the performance of various fungicides, including picoxystrobin, hexaconazole, isoprothiolane, kresoxim methyl, pyraclostrobin, tebuconazole, kitazin, and zineb, at varying dosage levels (100%, 75%, and 50% of the recommended dose). The findings of this investigation indicated that hexaconazole, isoprothiolane, kitazin, and zineb exhibited a 100% inhibition of P. oryzae growth across all tested doses. Pyraclostrobin also demonstrated a 100% inhibition at the highest dose, although its effectiveness decreased slightly at lower doses. In contrast, picoxystrobin and kresoxim methyl did not exhibit significant effectiveness in controlling the growth of the rice blast pathogen. These results provide valuable insights into the potential alternatives to tricyclazole for managing rice blast when used either alone or in combination at reduced doses. |
---|---|
ISSN: | 2394-1081 2394-1081 |
DOI: | 10.9734/jabb/2024/v27i101560 |